Brigid Makes - Vivani Medical Chief Officer
| VANI Stock | USD 1.34 0.01 0.75% |
Insider
Brigid Makes is Chief Officer of Vivani Medical
| Age | 68 |
| Address | 1350 South Loop Road, Alameda, CA, United States, 94502 |
| Phone | 415 506 8462 |
| Web | https://www.vivani.com |
Brigid Makes Latest Insider Activity
Tracking and analyzing the buying and selling activities of Brigid Makes against Vivani Medical stock is an integral part of due diligence when investing in Vivani Medical. Brigid Makes insider activity provides valuable insight into whether Vivani Medical is net buyers or sellers over its current business cycle. Note, Vivani Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Vivani Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Brigid Makes over six months ago Acquisition by Brigid Makes of 37500 shares of Vivani Medical subject to Rule 16b-3 |
Vivani Medical Management Efficiency
The company has return on total asset (ROA) of (0.2929) % which means that it has lost $0.2929 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.861) %, meaning that it created substantial loss on money invested by shareholders. Vivani Medical's management efficiency ratios could be used to measure how well Vivani Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.59. The current Return On Capital Employed is estimated to decrease to -0.71. As of now, Vivani Medical's Net Tangible Assets are increasing as compared to previous years. The Vivani Medical's current Asset Turnover is estimated to increase to 0.23, while Total Assets are projected to decrease to under 23.7 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Hing Wong | HCW Biologics | 70 | |
| Jeffrey CPA | Rallybio Corp | 54 | |
| Deepika PharmD | Pmv Pharmaceuticals | 47 | |
| MD FACP | AN2 Therapeutics | 76 | |
| Jo PalmerPhillips | Eliem Therapeutics | N/A | |
| Robert Hudkins | Tyra Biosciences | 68 | |
| Amy Conrad | Tyra Biosciences | N/A | |
| Morgan Conn | Pharvaris BV | 55 | |
| Josh Eizen | AN2 Therapeutics | N/A | |
| Kyle Breidenstine | PepGen | N/A | |
| Jennifer Cormier | PepGen | N/A | |
| Hiroomi MD | Tyra Biosciences | 60 | |
| Susan MS | Eliem Therapeutics | N/A | |
| MBA BS | AN2 Therapeutics | 49 | |
| Daniel Bensen | Tyra Biosciences | 48 | |
| MD FACP | Rallybio Corp | 73 | |
| Maryann Cimino | Pharvaris BV | N/A | |
| MBA MD | Entrada Therapeutics | 49 | |
| Michael Alley | AN2 Therapeutics | N/A | |
| Niels Svenstrup | PepGen | 54 | |
| Sonia DPHIL | PepGen | 38 | |
Management Performance
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.29 |
Vivani Medical Leadership Team
Elected by the shareholders, the Vivani Medical's board of directors comprises two types of representatives: Vivani Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vivani. The board's role is to monitor Vivani Medical's management team and ensure that shareholders' interests are well served. Vivani Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vivani Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brigid Makes, Chief Officer | ||
| Adam Mendelsohn, Chairman CoFounder | ||
| Truc MBA, Chief Officer | ||
| Donald MBA, Chief Secretary | ||
| Lisa MD, Chief Officer | ||
| Kayte Fischer, CoFounder |
Vivani Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vivani Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | 79.41 M | ||||
| Shares Outstanding | 59.23 M | ||||
| Shares Owned By Insiders | 52.50 % | ||||
| Shares Owned By Institutions | 10.46 % | ||||
| Number Of Shares Shorted | 754.37 K | ||||
| Price To Book | 4.33 X | ||||
| Gross Profit | 130 K | ||||
| EBITDA | (26.61 M) |
Currently Active Assets on Macroaxis
When determining whether Vivani Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vivani Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vivani Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vivani Medical Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivani Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivani Medical. If investors know Vivani will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivani Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.43) | Return On Assets (0.29) | Return On Equity (0.86) |
The market value of Vivani Medical is measured differently than its book value, which is the value of Vivani that is recorded on the company's balance sheet. Investors also form their own opinion of Vivani Medical's value that differs from its market value or its book value, called intrinsic value, which is Vivani Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivani Medical's market value can be influenced by many factors that don't directly affect Vivani Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivani Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivani Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivani Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.